Literature DB >> 19083053

Risk factors of reflux esophagitis in the cervical remnant following esophagectomy with gastric tube reconstruction.

Kazuhito Yajima1, Shin-Ichi Kosugi, Tatsuo Kanda, Atsushi Matsuki, Katsuyoshi Hatakeyama.   

Abstract

BACKGROUND: The risk factors and suitable treatment of reflux esophagitis (RE) of the cervical remnant in patients undergoing radical esophagectomy remain unclear. The aim of this study was to evaluate the risk factors in patients with RE in the cervical remnant.
METHODS: We retrospectively examined 141 consecutive patients who underwent esophagectomy and reconstruction with gastric tubing. RE was diagnosed by upper gastrointestinal endoscopy and graded according to the Los Angeles Classification. Statistically, 11 potential risk factors of RE were evaluated. The postoperative follow-up time ranged from 18 to 204 months (median 60 months).
RESULTS: Among a total of 141 patients, 48 (34%) had RE in the cervical remnant, with 14 (29%) cases categorized as grade B, nine (19%) as grade C, and 25 (52%) as grade D. The cumulative incidence of RE in the cervical remnant was 24% at 5 years after surgery and 60% at 10 years, respectively. Pyloroplasty and bile reflux were identified as independent risk factors of RE in the cervical remnant by univariate and multivariate analyses.
CONCLUSIONS: The results of this study show a high incidence and high grade of RE in the cervical remnant after esophagectomy. Routine endoscopic examination and suitable medication is required for the control of RE in the cervical remnant together with surgical procedures to avoid bile reflux.

Entities:  

Mesh:

Year:  2009        PMID: 19083053     DOI: 10.1007/s00268-008-9856-6

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  15 in total

1.  Combined 24-hour intraluminal pH and bile monitoring of the denervated whole stomach as an esophageal substitute.

Authors:  R Romagnoli; P Bechi; M Salizzoni; J M Collard
Journal:  Hepatogastroenterology       Date:  1999 Jan-Feb

2.  The endoscopic assessment of esophagitis: a progress report on observer agreement.

Authors:  D Armstrong; J R Bennett; A L Blum; J Dent; F T De Dombal; J P Galmiche; L Lundell; M Margulies; J E Richter; S J Spechler; G N Tytgat; L Wallin
Journal:  Gastroenterology       Date:  1996-07       Impact factor: 22.682

3.  Results of a nationwide study on the three-field lymph node dissection of esophageal cancer.

Authors:  K Isono; H Sato; K Nakayama
Journal:  Oncology       Date:  1991       Impact factor: 2.935

4.  Denervated stomach as an esophageal substitute recovers intraluminal acidity with time.

Authors:  C Gutschow; J M Collard; R Romagnoli; M Salizzoni; A Hölscher
Journal:  Ann Surg       Date:  2001-04       Impact factor: 12.969

5.  Gastric functions in patients with the intrathoracic stomach after esophageal surgery.

Authors:  N Okada; O Nishimura; T Sakurai; S Tsuchihashi; M Juhri
Journal:  Ann Surg       Date:  1986-08       Impact factor: 12.969

6.  High incidence of reflux esophagitis observed by routine endoscopic examination after gastric pull-up esophagectomy.

Authors:  Shunsuke Shibuya; Shin Fukudo; Ryuzaburo Shineha; Shukichi Miyazaki; Go Miyata; Koh Sugawara; Takahiro Mori; Shuichi Tanabe; Norio Tonotsuka; Susumu Satomi
Journal:  World J Surg       Date:  2003-04-28       Impact factor: 3.352

7.  Radical lymph node dissection for cancer of the thoracic esophagus.

Authors:  H Akiyama; M Tsurumaru; H Udagawa; Y Kajiyama
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

8.  Indications, surgical technique, and long-term functional results of colon interposition or bypass.

Authors:  T R DeMeester; K E Johansson; I Franze; E Eypasch; C T Lu; J E McGill; G Zaninotto
Journal:  Ann Surg       Date:  1988-10       Impact factor: 12.969

9.  Clinical analysis of reflux esophagitis following esophagectomy with gastric tube reconstruction.

Authors:  Soichiro Yamamoto; Hiroyasu Makuuchi; Hideo Shimada; Osamu Chino; Takayuki Nishi; Yoshifumi Kise; Takahiro Kenmochi; Tadashi Hara
Journal:  J Gastroenterol       Date:  2007-05-25       Impact factor: 7.527

10.  Esophageal reconstruction.

Authors:  D B Skinner
Journal:  Am J Surg       Date:  1980-06       Impact factor: 2.565

View more
  6 in total

1.  Gastric tube reconstruction reduces postoperative gastroesophageal reflux in adenocarcinoma of esophagogastric junction.

Authors:  Xiu-Feng Chen; Bo Zhang; Zhi-Xin Chen; Jian-Kun Hu; Bin Dai; Fang Wang; Hong-Xin Yang; Jia-Ping Chen
Journal:  Dig Dis Sci       Date:  2011-09-28       Impact factor: 3.199

2.  The Impact of the Location of Esophagogastrostomy on Acid and Duodenogastroesophageal Reflux After Transthoracic Esophagectomy with Gastric Tube Reconstruction and Intrathoracic Esophagogastrostomy.

Authors:  Hiroaki Usui; Masahide Fukaya; Keita Itatsu; Kazushi Miyata; Ryoji Miyahara; Kohei Funasaka; Masato Nagino
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

3.  Impact of the Level of Anastomosis on Reflux Esophagitis Following Esophagectomy with Gastric Tube Reconstruction.

Authors:  Makoto Sakai; Makoto Sohda; Tatsuya Miyazaki; Tomonori Yoshida; Yuji Kumakura; Hiroaki Honjo; Keigo Hara; Takehiko Yokobori; Hiroyuki Kuwano
Journal:  World J Surg       Date:  2017-03       Impact factor: 3.352

Review 4.  [Management of delayed complications after esophagectomy].

Authors:  A Beham; S Dango; B M Ghadimi
Journal:  Chirurg       Date:  2015-11       Impact factor: 0.955

5.  Comparison of Long-term Quality of Life in Patients with Esophageal Cancer after Ivor-Lewis, Mckeown, or Sweet Esophagectomy.

Authors:  Yu-Shang Yang; Qi-Xin Shang; Yong Yuan; Xiao-Ying Wu; Wei-Peng Hu; Long-Qi Chen
Journal:  J Gastrointest Surg       Date:  2018-10-08       Impact factor: 3.452

6.  A flow visualization model of duodenogastric reflux after esophagectomy with gastric interposition.

Authors:  Chul-Hyun Park; Jae-Ik Lee; Jaeyong Sung; Sunghoon Choi; Kwang-Pil Ko
Journal:  J Cardiothorac Surg       Date:  2013-09-25       Impact factor: 1.637

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.